Malawi medical device regulations

Complete 11-page official Gazette instrument, printed pages 183–193, made and published on 27 March 2026 and expressly effective from 1 April 2026. Regulation 2 replaces the First Schedule of the Fees and Forms Regulations, GN 9/2022; it does not repeal the whole parent or replace its Second Schedule forms. The entire new fee schedule is retained, including medical-device premises licensing/retention, device registration and retention for classes I–III, imports, inspections, advertising, general post-registration-change fee categories and all notes. Original columns and currency distinctions are preserved. The schedule does not itself define a complete device variation classification, submission procedure or review timeline. The complete 2022 parent and all 25 Second Schedule forms are retained separately as a dated amended original. Device-specific implementing requirements, later form updates and subsequent amendments remain under review.

Complete enacted Act No. 3 of 2024: all 53 sections, ten Parts, arrangement and enactment records, preserved by CYRILLA. Presidential assent was 31 January 2024, publication was 2 February 2024, and Government Notice 40 separately appoints 3 June 2024 as commencement. This cross-cutting law covers personal, health, biometric and research data, including impact assessments, controller–processor contracts and international transfers referenced by KUREC templates. It does not establish medical-device market approval procedures. Section 41(3) requires a decision on significant controller/processor registration within fourteen days; section 41(6) requires written notification within ninety days after registration information changes. These periods, breach notifications, data-subject responses and original transitional periods are not device-modification approval deadlines. All thirty original page images and complete text are retained, including the original Major/Significant Importance heading difference, extraneous marginal Complaints on page 24 and penalty of make good in section 45(5). The DPA catalogue links the Act, but its actual download timed out; this preservation copy has not been compared with that unreceived file. Three currently linked 2025 regulations are expressly drafts, and the July 2026 fee notice concerns proposed fees. This original expression is not a verified current consolidation. Later amendments, enacted regulations, prescribed forms/fees, orders and current applicability remain under review; excluded from default current-law discovery.

Complete four-page original Gazette instrument, printed pages 53–56 in Supplement No8A, made on 4 March 2024, published on 22 March and expressly effective from 1 April 2024. Regulation 2 replaces the entire Schedule to GN62/2021, not the whole parent. All ten categories, 74 amount rows and the radiation-emitting-device import formula are retained, with all four original page images. Medical rows include X-ray, mammography, fluoroscopy, CT, C-Arm, PET/CT and radiotherapy; other sections cover industrial/NORM practices, service providers including medical equipment suppliers and maintenance, inspections, transport, monitoring, dosimetry, imports and exports. Item9 charges one and half percent of the stated CIF value for import of radiation-emitting devices; this must not be generalized to every medical device or to a variation filing. Original overlapping source-count bands, unit lettering, grammatical inconsistencies and scrap mental wording are preserved. The cross-page item3(d) remains complete with its amount on the following page. Licence/service validity periods are not application review deadlines. The complete dated amendment is retained, while subsequent amendments and current operational applicability remain under review; it is excluded from default current discovery until that review is resolved. The original government Gazette is held by the Gazettes Africa archive.

Complete 70-page original Gazette Act supplied by PMRA, including 135 sections and the Schedule. Medical devices, medical/surgical sundries, reagents and condoms fall within allied substances. The Act establishes authorisation, premises, import/export, inspection, advertising, safety-surveillance and enforcement powers. Assent is 19 February 2019 and Gazette publication is 22 February 2019. The separately retained reproduced Government Notice 69 appoints 1 October 2019 as the Act commencement; the notice is made on 2 October and its Gazette publication date is still being corroborated. Sections 47–49 concern premises-licence transfer, amendments and duplicate certificates. Section 48(2) requires notification within fourteen days after specified registered particulars change; it is not a universal product-variation approval period. Section 128(2) requires guidelines under that section to be published in the Gazette. Section 130 repeals the former Act while conditionally preserving existing subsidiary legislation unless conflicting with this Act or later replaced, amended, revoked or repealed. This original expression is not a verified current consolidation. The current authority download was retrieved again with unchanged source bytes; later amendments, Gazette implementation and device/IVD-specific requirements remain under review. Excluded from default current-law discovery.

Complete public AERA guidance body, including the overview, six functions, eight regulated-activity examples, six application stages and all five FAQs. It expressly requires notification and prior written approval for significant changes affecting safety, security or compliance, including facilities, equipment, ownership, Radiation Safety Officers and authorized scope. It describes licensing amendments and renewals without stating a fixed review period; expected processing times refer to the still-unretrieved Service Charter. The prescribed application forms and underlying guidance are referenced but not supplied here. The undated page is retained as an authority website snapshot, not a new statutory instrument or proof that the entire radiation/device framework is current. Responsive carousel copies are represented once per public content record. No publication/effective date or legal Gazette number is invented.

Complete public AERA guidance body, including six provider descriptions, six categories, all five interactive certification explanations, six eligibility criteria, six process stages and six FAQs. Medical radiological equipment suppliers, installation/maintenance/repair, calibration and dosimetry services are expressly included. The five tabs were opened and matched to declarative public records; responsive carousel duplicates are excluded without removing repeated conditions from distinct records. Effective and expiry dates are described as fields on each registration certificate, not dates of this undated web guidance. Authorization may be amended, suspended or revoked, and renewal is required before its stated expiry. Processing times refer to the unresolved Service Charter; prescribed application forms and the official service-provider register are referenced without supplied originals. This snapshot is currentness-unverified and excluded from default current-law discovery; no statutory number or publication/effective date is invented.

Complete public AERA guidance body, including seven authorization types, six process stages, all three interactive exemption explanations, three post-certification duties and six FAQs. It distinguishes licensing of high-energy radiation-generating equipment from registration of low-energy equipment, addresses radiotherapy facility stages and import/export, and states that certification or permits cannot be transferred to another person or organization without prior written approval. The three exemption tabs were opened and compared with the public page payload; they are absent from the static server-rendered body and are retained in full. No fixed application turnaround is given. This undated authority guidance is not a substitute for the Atomic Energy Act, 2012 regulations, applicable exemption levels or individual authorization conditions; current legal applicability and later versions remain under review. No publication/effective date or Gazette identifier is inferred.

Complete undated public AERA inspection/enforcement guidance: full overview, five regulatory functions, five process stages, both interactive inspection categories with all ten listed criteria, incident reporting and all seven FAQs. Both routine and reactive tabs were opened in the official browser and compared with the source-bound declarative page records. The page expressly cites Act16/2011 and applicable2012regulations as its inspection authority; this is an authority statement in a website snapshot, not proof that no later law or amendment exists. It requires incident notification within24hours and a detailed written report within7days, including reports of damaged or missing radiation equipment. These are incident duties, not device variation approval times. Corrective-action periods are specified case by case; no fixed universal period is supplied. Required records include licences, dosimetry, equipment maintenance/calibration, training, incident and inventory records. Standardized inspection checklists are referenced without supplied originals. Unrendered CMS drafting text is excluded; responsive copies of the same content record are represented once. Guidance remains currentness-unverified and excluded from default current discovery; no publication/effective date or separate legal code is invented.

Complete public AERA/NDL monitoring guidance body, including all three More Details dialogs, monthly and quarterly service charges/conditions, five subscription stages and seven FAQs. Monthly MWK30000/person, quarterly MWK60000/person and lost/irreparably-damaged TLD MWK150000/badge are preserved as the page states; they do not prove there is no later fee instrument. Thirty-day advance amendments concern monitored-worker numbers for the intended monitoring period; ten working days concerns dose reports. Both pricing dialogs separately require at least thirty days written notice for termination and allow suspension when invoices remain unpaid more than thirty days after issue; these are service conditions, not device variation approval periods. Courier costs and periodic fee review are retained. The public service-information dialog visibly includes an unedited CMS authoring prompt; that publisher text is preserved rather than silently cleaned. Unrendered CMS drafting fields, empty content sections and unrelated runtime config are excluded. Application/service agreement/dispatch forms are referenced but not supplied. Undated guidance remains currentness-unverified with no invented publication/effective date or legal number.

Complete undated public AERA training guidance: full overview, four training/audience categories, four completion-certificate categories and all six FAQs. Training may be required as a condition of licensing or compliance depending on the activity; the page does not say every course is universally compulsory. Radiation Safety Officer training and certificates of participation/completion do not by themselves grant authorization for a regulated activity. Registration/schedules/fees refer readers to AERA; no prescribed registration form, fixed turnaround or dated course schedule is supplied. The archived upcoming-trainings section explicitly says No Trainings Available Yet; its complete rendered notice is preserved with a separate text SHA bound to the original HTML. It is a dated observation of this website response, not proof that no training is offered or required. The notice is outside the empty declarative content records, so it is separately retained rather than lost or invented from an empty array. All ordinary headings/paragraphs/lists are conserved and original layout order retained. Guidance is currentness-unverified/default-current excluded, with no fabricated publication/effective date or statutory identifier.

Complete original enacted Act16/2011, physical pages3–41/printed1–39 of the FAOLEX-hosted compound PDF; the first two Bill notice/memorandum pages are excluded. All83 operative sections, full arrangement, enacting formula, presidential assent18August2011, publication19August2011 and Parliament terminal31May2011/M.M.Katopola are retained with every original page image. Reviewed native columns restore marginal captions before their own sections without interrupting clauses; no alphanumeric characters are missing or added across all39pages. Original TOC duplicate82, PartVII title discrepancy, Pelindaba1966 wording, compela and other publisher grammar/numbering remain as printed. Section3 covers ionizing-radiation activities and excludes non-ionizing sources; sections45–46 expressly address medical practices, equipment/device design and performance, and patient protection. Sections7(d/e),24(c),25(1)(j),27 and31(3) provide licensing/modification authority and information duties. Section28(2)ninety days concerns written refusal notification/reasons from receipt, not a general variation approval timetable. Section33sixmonths concerns intended termination,34twentyfourhours incident reporting,41fourteendays compliance representations/orders,78thirtydays appeal/judicialreview and83two/three months original transition; none is a general device-variation service deadline. Section62(3) belongs to mining/processing and is not generalized to every device. Original section1 requires separate Gazette commencement notice(s) and allows different dates for different Parts; no exact effective date is inferred from assent, publication or the differently edited as-at2014reproduced edition. The fetched22June2012ordinaryGazette contains only company notices, not that commencement notice. This complete dated original is not a2026consolidation; the complete dated2012regulations/all five Schedules are separately retained; current amendments, commencement and operational guidance remain under review, and default current discovery excludes it.

Complete one-page original Gazette instrument, printed page 361, with all five regulations, the making clause of 12 November 2021, Minister Nancy Tembo and file reference. Regulation 2 replaces principal regulation 14(2) with a reference to the Atomic Energy (Fees) Regulations and deletes 14(3); regulations 3 and 4 replace Fifth Schedule fee references in principal regulations 17(1) and 64(1). Regulation 5 expressly revokes the principal Fifth Schedule. It does not repeal the whole 2012 principal instrument. The original 5.—(1) numbering and marginal captions are preserved. The separately retained GN62/2021 establishes the companion fees. Source text was visually transcribed against the complete original page; the government Gazette is held by MalawiLII, not on a regulator host. Published on 10 December 2021; no exact commencement date is inferred from the making or publication date. The complete GN22/2012 principal instrument is separately retained; later amendments and current applicability remain under review; this dated original is excluded from default current discovery.

Complete four-page original Gazette instrument, printed pages 362–365, containing both operative regulations, all seven Schedule categories and 63 monetary rows, the 12 November 2021 making clause, Minister Nancy Tembo, file number and Government Printer terminal. It covers medical equipment and practices, industrial irradiation, naturally occurring radioactive materials, service providers, inspections, transport and dosimetry. Every page was visually transcribed and retained as an original image. The inconsistent 24 December running header on printed page 363 and Potasium spelling remain as printed; the Gazette cover and the other pages identify publication as 10 December 2021. Amounts displaced or misread by hidden OCR were verified against original cells. GN16/2024 expressly replaces the whole Schedule from 1 April 2024, so these 2021 rates are historical and must not be used as current charges. The two-regulation parent is not wholly repealed by that schedule amendment. Stated annual, two-year and five-year periods describe the relevant licences or services, not device variation approval times. Exact original commencement and later amendments/currentness remain under review; default current discovery excludes this dated original. The government Gazette is supplied through MalawiLII.

Complete original Gazette GN22/2012, all 54 physical pages/printed 311–364, with full arrangement, 90 regulations, all five Schedules, making clause dated 31 July 2012, Minister Catherine Gotani Hara, file EAD/99/05/52 and Government Printer terminal. Published 31 August 2012 in Supplement No13A; no exact commencement is inferred from making or publication. The regulations address medical exposure, equipment design, calibration, procurement, licensing and Category1/2 source import/export. Regulation18(3) requires notification of intended modifications with significant safety implications and specific authorization before implementation;19(2)(c) requires reporting intended significant-safety modifications, while56(a) subjects new or significantly modified external-irradiation layouts affecting public exposure to review/approval before commissioning. These are distinct duties. Ninety days in15/17 concerns initial notification/application for pre-existing practices;24hours/sevendays concern incidents/reports;64(4)(b) concerns advance export-shipment notification, not a fixed device variation review period. All original page images and complete text are retained after individual visual review, corrected native font mappings, ordered body/caption review and exact numeric-row checks. All26 radionuclide rows/156 cells, both original five-category tables, notification form, medical operational requirements, aggregation equation and25 historical monetary rows remain complete. Source greater-than-or-equal symbols, mathematical subscripts and footnote markers are restored from visible pages; original Cf252 5.E-00, duplicate17 subregulations/90(3), page54 anD and and, cross-reference errors, 3/6 count-band gaps and export per import wording are preserved. GN61/2021 amends fee references in14/17/64 and revokes the Fifth Schedule only; the original2012 amounts are historical, not current charges. Referenceslist and certain footnotes are cited but not supplied in this54page object. This dated original is not a2026 consolidation; later instruments, referenced standards, commencement and operational applicability remain under review, and default current discovery excludes it.

Complete twelve-page December 2012 revised second-edition policy, including all nine main sections, study categories, eleven review criteria, seven insurance-certificate bullet fields, both footnotes, source contacts, acknowledgment and contents. Section 2.3.1.5 explicitly includes a trial involving a medical device that has not been prequalified by WHO and approved for usage; other studies are subject to case-specific committee determination. The source requires no-fault insurance while retaining causal connection between trial participation and harm, local insurer/broker arrangements, site- and trial-specific cover, notarial certification and Reserve Bank approval of fronting arrangements. Coverage during the trial plus five years after completion or closure is an insurance condition, not a device-variation approval period. Professional indemnity/malpractice insurance is expressly excluded as a substitute. Original misspellings, 2.4.2 numbering, 2.2.1/2.2.2 cross-references and historical COMREC/drug-authority names are preserved. The source month and edition are document context; no exact publication or commencement date is inferred from the 2025 upload path. The 2008 predecessor, subsequent changes, committee authority and current implementation remain under review; excluded from default current-law discovery.

Complete Government Notice 40 on physical page 3 of Malawi Gazette Supplement No. 16A of 31 May 2024, with the original enacting formula, ministerial name/signature, file number and Government Printer imprint. Acting under section 1 of the Data Protection Act No. 3 of 2024, the Minister appoints 3 June 2024 as the date on which that Act comes into operation. That is the parent Act commencement, not an inferred separate commencement date for this notice. Government Notice 39 in the same issue concerns business-licensing fees and is excluded from this expression; the contrary reference number in the NIH directory is not adopted. The original notice is preserved by the Gazette archive; it is not described as hosted by the issuing ministry. This supports the research-data protection chain referenced in KUREC transfer templates, rather than supplying a device-modification approval period. The complete enacted parent Act expression is now separately retained; later regulations/amendments and current applicability remain under review; excluded from default current-law discovery.

Complete undated four-page Ministry of Health Research Unit summary preserved from the NIH ClinRegs reference copy. All twelve sections and thirteen protocol-content subsections, submission/contact details, meeting/submission information, fees, review criteria, expedited-review examples and closing specimen statement remain intact with original page images. The source says NHSRC meets every two months and COMREC monthly, with applications at least three weeks before the meeting; these are meeting frequency and submission cutoffs. It allows arrangements to expedite modified protocols without a fixed turnaround. Historical committee jurisdiction, $150/10% fee wording and special student rates require current-version and applicability reconciliation. The original fax prefix +235 is preserved. This is an NIH-hosted Ministry copy, not a newly issued NIH policy or a verified 2026 procedure. No issue/effective date or statutory relationship is inferred. Currentness remains under review and default current-law discovery excludes this source.

Complete November 2012 revised policy: all 24 physical pages, twelve main sections, four footnotes, nine reference entries and original page images. It builds on the 2005 edition and cites sections 18 and 48 of the 2003 Act. The policy addresses human health/biomedical research, the historical NHSRC/COMREC jurisdictions, multicentre studies, study extension and institutional affiliation. Section 8 expressly concerns trials involving pharmaceutical products; its sequential ethics/drug-authority approval and amendment requirements are not generalized to independent medical devices. Four weeks concerns an optional pre-submission meeting request. Section 9 requires continuing review and addresses studies not started within one year; it supplies no general variation-review deadline. The 120 days from 1 March 2013 concerns the historical MOU transition, rather than the effective date of the entire policy. Original wording and references remain unchanged. The two-committee statement is not presented as a verified 2026 inventory. The 2005 predecessor, current committee recognition/SOPs, references and later implementation remain under review; excluded from default current-law discovery.

Complete undated one-page official account-details document, preserving the published account name/number, bank, branch, SWIFT and instruction to upload the deposit slip with the protocol via REIMS. This is an administrative payment-instruction original, without an asserted fee amount, legal issuance date or device-variation deadline. The 2026 upload path is retrieval context only. Current KUHeS research-ethics page links this exact original. Dated form versions are preserved as document context, without asserting legal publication, commencement or supersession dates. Complete Office renders retain source layout. Later changes, signed delegation and medical-device/IVD applicability remain under review; excluded from default current-law discovery.

Complete Amendment Version 1.0 dated 12 February 2026. Preserves the mandatory KUREC reference number, investigator/contact fields, proposed changes, reason, consent-form question, signatures, office-only approval and recommended/not-recommended decision. Changes may not be implemented before KUREC approval; no uniform review period is stated. All three rendered pages are retained, including the footer-only third page. The standalone file has no printed Form 103 identifier; the separately bundled SOP appendix does, so that number is not invented for this expression. Current KUHeS research-ethics page links this exact original. Dated form versions are preserved as document context, without asserting legal publication, commencement or supersession dates. Complete Office renders retain source layout. Later changes, signed delegation and medical-device/IVD applicability remain under review; excluded from default current-law discovery.

Complete Progress Report Version 1.0 dated 12 February 2026 linked as the Annual Renewal Form. Preserves fields 1–17, sponsor/funder footnotes, the full progress summary and sections A–E, participant counts, safety/change/conflict questions, all investigator responsibilities, REIMS upload instruction and office reapproval/signature fields. All seven rendered pages and 37 visible checkboxes are retained, including the additional checkbox on the split item continuation. The printed page numbering starts at 3; it is not silently renumbered as an official PDF. Protocol and consent changes require prior approval; no uniform device-variation deadline is supplied. Current KUHeS research-ethics page links this exact original. Dated form versions are preserved as document context, without asserting legal publication, commencement or supersession dates. Complete Office renders retain source layout. Later changes, signed delegation and medical-device/IVD applicability remain under review; excluded from default current-law discovery.

Complete two-page Version 1 checklist dated 12 February 2026, preserving all proposal contents, consent/assent ages and languages, attachments, support letters, clinical-investigator registration, waiver question, signatures and all 60 Yes/No checkboxes. It requests evidence of the source US150 processing fee and an emailed single PDF up to 5MB (zipped if larger). Those source submission instructions differ from the online-platform instructions elsewhere in the current official materials; no replacement hierarchy is inferred. The separately named Elements of Review attachment is not supplied inside this two-page file. This checklist is not a device-marketing variation timetable. Current KUHeS research-ethics page links this exact original. Dated form versions are preserved as document context, without asserting legal publication, commencement or supersession dates. Complete Office renders retain source layout. Later changes, signed delegation and medical-device/IVD applicability remain under review; excluded from default current-law discovery.

Complete 2026 calendar: all eleven full-committee submission deadlines and meeting dates for January–November, and all expedited/safety subcommittee entries through December. December contains two expedited dates and no safety date; no missing meeting is invented. Two publisher download URLs are byte-identical and recorded as duplicate sources of this one expression. Calendar dates describe scheduled submissions/meetings, not guaranteed review completion, elapsed approval times or later-year schedules. Current KUHeS research-ethics page links this exact original. Dated form versions are preserved as document context, without asserting legal publication, commencement or supersession dates. Complete Office renders retain source layout. Later changes, signed delegation and medical-device/IVD applicability remain under review; excluded from default current-law discovery.

Complete Version 1 Data Transfer Agreement template dated 6 May 2026: all 23 clauses, signatures and Annexures A–D, including the blank insert placeholders. Source numbering repeats, legislative-title/year references differ internally, and section 17q is retained as printed; those references are not verified statutory text. All contractual notice, breach, rights-request, termination and dispute periods remain tied to their own conditions; none is a device-variation approval period. The illustrative MK2,000,000 liability amount retains its express adjustable/illustrative qualification. A QA render preserves the original cached cross-reference to clause 5, with documented preparation and unchanged original bytes; the automatic direct-render reference error is excluded. Current KUHeS research-ethics page links this exact original. Dated form versions are preserved as document context, without asserting legal publication, commencement or supersession dates. Complete Office renders retain source layout. Later changes, signed delegation and medical-device/IVD applicability remain under review; excluded from default current-law discovery.

Complete nine-page Material Transfer Agreement Form dated 6 May 2026, including sections 1–5.1, all transfer/ownership/confidentiality/liability/termination terms and the full signature/approval form. Preserves government ownership and recall wording, justification and consent requirements, no-sale condition, initial sample-storage authorization up to five years with further authorization, the Data Protection Act No. 3 of 2024 reference, repeated field letters and the source NCST wording in the liability clause. The original image-letterhead contacts and footer-only ninth page are retained. These are research-material-transfer terms, not a blanket marketing-authorization modification rule. Current KUHeS research-ethics page links this exact original. Dated form versions are preserved as document context, without asserting legal publication, commencement or supersession dates. Complete Office renders retain source layout. Later changes, signed delegation and medical-device/IVD applicability remain under review; excluded from default current-law discovery.